Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Evolent Health, Inc. | evh12311910-k.htm |
| EX-32.2 - EXHIBIT 32.2 - Evolent Health, Inc. | a123119exhibit322.htm |
| EX-32.1 - EXHIBIT 32.1 - Evolent Health, Inc. | a123119exhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - Evolent Health, Inc. | a123119exhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - Evolent Health, Inc. | a123119exhibit311.htm |
| EX-23.2 - EXHIBIT 23.2 - Evolent Health, Inc. | a123119exhibit232pwcco.htm |
| EX-21.1 - EXHIBIT 21.1 - Evolent Health, Inc. | a123119exhibit211.htm |
| EX-4.8 - EXHIBIT 4.8 - Evolent Health, Inc. | a123119exibit48.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-212709 and 333-219755 on Form S-3 and Registration Statement Nos. 333-204785 and 333-225714 on Form S-8 of our reports dated March 2, 2020, relating to the financial statements of Evolent Health, Inc. and subsidiaries (the “Company”) and the effectiveness of the Company’s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ Deloitte & Touche LLP
McLean, Virginia
March 2, 2020